Phase II trial of paclitaxel and cisplatin in women with advanced breast cancer: an active regimen with limiting neurotoxicity.Carolyn Wasserheit, J Speyer, Andrea Frazein et al.|Journal of Clinical Oncology|1996Cited by 87
A phase I and pharmacokinetic study of docetaxel combined with Doxil (pegylated liposomal doxorubicin) without and with granulocyte colony stimulating factorAnna C. Pavlick, Franco M. Muggia, Catherine Chodkiewicz et al.|Anti-Cancer Drugs|2004Cited by 12
Safety of prolonged Doxil administration in recurrent gynecologic cancersFranco M. Muggia, Anne Hamilton, E. Kim et al.|Journal of Clinical Oncology|2004Cited by 7
Intraperitoneal Topoisomerase‐I Inhibitors: Preliminary Findings with 9‐AminocamptothecinFranco M. Muggia, Heather Wasserstrom, Leonard Liebes et al.|Annals of the New York Academy of Sciences|2000Cited by 4
Safety of prolonged Doxil administration in recurrent gynecologic cancersFranco M. Muggia, Anne Hamilton, E. Kim et al.|Journal of Clinical Oncology|2004Cited by 1